Crestline Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-1
Closed -$82K 289
2022
Q1
$82K Buy
+1
New +$82K 0.01% 251